Hyperhomocysteinemia in chronic hepatitis C: Role in steatosis, fibrogenesis and response to antiviral treatment

被引：1
|
作者：
Roblin, X. [1 ]
Ducros, V. [1 ]
Hilleret, M. N. [1 ]
Sturm, N. [1 ]
Plages, A. [1 ]
Zarski, J. P. [1 ]
Leroy, V. [1 ]
机构：
[1] INSERM, U548, Dept Hepatogastroenterol, Grenoble, France
来源：
JOURNAL OF HEPATOLOGY | 2007年 / 46卷
关键词：
D O I：
10.1016/S0168-8278(07)62149-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
551
引用
下载
收藏
页码：S209 / S210
页数：2
相关论文
共 50 条
  • [21] The presence of severe steatosis or steatohepatitis impairs response to antiviral therapy in patients with chronic hepatitis C.
    Harrison, SA
    Brunt, EM
    Oliver, DA
    Neuschwander-Tetri, BA
    Di Bisceglie, AM
    Bacon, BR
    HEPATOLOGY, 2003, 38 (04) : 626A - 626A
  • [22] Steatosis influences cytokine response in chronic hepatitis C
    Fernandez, L.
    Gonzalez, J. M.
    Leon, A.
    Alvarez, T.
    Aller, R.
    Velayos, B.
    Garrote, J. A.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S171 - S171
  • [23] The role of steatosis and diabetes as a predictor of treatment response to interferon based therapies in Latino Americans with chronic hepatitis C
    Mena, Edward A.
    Ventura, Orlinda E.
    Blatt, Lawrence M.
    Tong, Myron J.
    HEPATOLOGY, 2007, 46 (04) : 397A - 397A
  • [24] Antiviral Treatment of Children with Chronic Hepatitis C
    Romanova, S., V
    Zhukova, E. A.
    Kaplina, N. A.
    ALLERGY, ASTHMA AND IMMUNOLOGY: FROM GENES TO CLINICAL APPLICATION: PROCEEDINGS OF THE IV WORLD ASTHMA AND COPD FORUM AND XVI INTERNATIONAL CONGRESS ON REHABILITATION IN MEDICINE AND IMMUNOREHABILITATION, 2011, : 211 - 213
  • [25] Mild chronic hepatitis C with steatosis: Which treatment?
    Durante-Mangoni, E
    Zampino, R
    Ruggiero, G
    Adinolfi, LE
    HEPATOLOGY, 2005, 41 (05) : 1198 - 1198
  • [26] Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C
    Adinolfi, LE
    Ingrosso, D
    Cesaro, G
    Cimmino, A
    D'Antò, M
    Capasso, R
    Zappia, V
    Ruggiero, G
    HEPATOLOGY, 2005, 41 (05) : 995 - 1003
  • [27] Reassessing Effects of Hepatic Steatosis on Response to Direct Acting Antiviral Therapy for Chronic Hepatitis C Virus Treatment in a Real World Setting
    Gomez, Paul A.
    Zucker, Kelly
    Chang, Jean
    Rowley, Michael William
    Seetharam, Anil B.
    HEPATOLOGY, 2018, 68 : 370A - 370A
  • [28] Quasispecies as predictive response factors for antiviral treatment in patients with chronic hepatitis C
    Salmeron, Javier
    De Rueda, Paloma Munoz
    Ruiz-Extremera, Angela
    Casado, Jorge
    Huertas, Carlos
    Bernal, Maria Del Carmen
    Rodriguez, Luis
    Palacios, Angel
    DIGESTIVE DISEASES AND SCIENCES, 2006, 51 (05) : 960 - 967
  • [29] Quasispecies as Predictive Response Factors for Antiviral Treatment in Patients with Chronic Hepatitis C
    Javier Salmerón
    Paloma Muñoz De Rueda
    Ángela Ruiz-Extremera
    Jorge Casado
    Carlos Huertas
    Maria Del Carmen Bernal
    Luis Rodríguez
    Ángel Palacios
    Digestive Diseases and Sciences, 2006, 51
  • [30] The impact of liver steatosis on early and sustained treatment response in chronic hepatitis C patients
    Gaman, Alice Elena
    Ungureanu, Anca Marilena
    Turculeanu, Adriana
    Gheonea, Dan Ionut
    Drocas, Andrei Ioan
    Mitroi, George
    Dobritoiu, Maria
    Comanescu, Maria Victoria
    Stanculescu, Andreea Doriana
    Cioboato, Ramona
    Jieanu, Claudiu Florin
    Tomescu, Paul Ioan
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2017, 58 (01): : 107 - 113
12345